Statistics for Biosyent Inc (id:1299 RX)
Valuation metrics
Market cap
134.84M
Enterprise value
114.65M
Trailing P/E (ttm)
19.38
Forward P/E
20.77
PEG ratio
20.77
Price/Sales (ttm)
3.99
Price/Book (mrq)
3.93
Enterprise Value/Revenue
3.39
Enterprise Value/EBITDA
13.38
Overview
Shares outstanding
11.59M
Float
8.98M
Shares short
357.00
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
1.93K
Average volume (90 days)
Price summary
52-Week low
8.24
52-Week high
12.13
52-Week change
21.64%
Beta
3.00
50-Day moving average
11.15
200-Day moving average
9.90
Dividends and splits
Forward annual dividend rate
3.00
Forward annual dividend yield
5.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
3.00
Dividend date
December 16, 2024
Ex-dividend date
September 4, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
21.14%
Operating margin
21.54%
Operational effectiveness
Return on assets
12.86%
Return on equity
20.88%
Income statement
Revenue (ttm)
2.88
Revenue per share (ttm)
2.88
Quarterly revenue growth (yoy)
5.00
Gross profit (ttm)
25.60M
EBITDA
9.92M
Net income to common (ttm)
7.15M
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
6.50%
Balance sheet
Total cash (mrq)
17.41M
Total cash per share (mrq)
1.50
Total debt (mrq)
1.13M
Total Debt/Equity (mrq)
3.19
Current ratio (mrq)
613.20%
Book value per share (mrq)
2.96
Cash flow
Cash flow statement
2.53M
Levered free cash flow (LFCF)
1.75M